Olainfarm AS logo

OLF1R - Olainfarm AS Share Price

€7.1 0.1  0.9%

Last Trade - 12/08/20

Small Cap
Market Cap £90.4m
Enterprise Value £90.4m
Revenue £121.9m
Position in Universe 171st / 748
Unlock OLF1R Revenue
Relative Strength (%)
1m -0.57%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -8.97%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
93.7 97.4 110.7 122.1 124.3 137.2 142 151 +7.9%
-1.3 +26.1 -19.0 -3.1 -3.5 +148.6 -61.3 +4.94
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Olainfarm AS revenues decreased 7% to EUR32.4M. Net income decreased 74% to EUR2.1M. Revenues reflect Medicine Production segment decrease of 18% to EUR17.8M. Net income also reflects Finance expense increase from EUR161K to EUR4.2M (expense), Finance income decrease of 99% to EUR18K (income). Basic Earnings per Share excluding Extraordinary Items decreased from EUR0.59 to EUR0.15.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for OLF1R
Graphical History


OLF1R Revenue Unlock OLF1R Revenue

Net Income

OLF1R Net Income Unlock OLF1R Revenue

Normalised EPS

OLF1R Normalised EPS Unlock OLF1R Revenue

PE Ratio Range

OLF1R PE Ratio Range Unlock OLF1R Revenue

Dividend Yield Range

OLF1R Dividend Yield Range Unlock OLF1R Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
OLF1R EPS Forecasts Unlock OLF1R Revenue
Profile Summary

Olainfarm AS is a Latvia-based company engaged in the pharmaceutical sector. The Company is active in the production of basic pharmaceutical products and pharmaceutical preparations. The Company’s activities include numerous finished forms of medicaments with effects, which include cardiological, neurologic, diuretic, spasmologic and antiallergic drug preparations, medicaments treating the digestive system, antibiotics and food supplements, as well as various active chemical ingredients and raw chemical materials. Its products include Amlodipine, Clonazepam, Euphillin, Furosemide, Furagin, Midolat, Protionol and Gripoflex, among others. The Company operates through its subsidiaries which includes Reinolds SIA, Ozols JDR SIA, Olainfarm energija SIA, Ilmas Aptiekas SIA and Veritas-Farm, among others. In addition, the Company has 33 pharmacies, located in Riga, Vidzeme, Kurzeme and Latgale. In May 2013, it acquired a 47.5% shares in pharmaceutical manufacturer SIA Silvanols.

Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated June 10, 1991
Public Since June 9, 1997
No. of Shareholders: n/a
No. of Employees: 2,166
Sector Healthcare
Industry Pharmaceuticals
Exchange OMX Baltic Exchange - Riga
Shares in Issue 14,085,078
Free Float (0.0%)
Eligible for
OLF1R Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for OLF1R
Upcoming Events for OLF1R
Frequently Asked Questions for Olainfarm AS
What is the Olainfarm AS share price?

As of 12/08/20, shares in Olainfarm AS are trading at €7.1, giving the company a market capitalisation of £90.4m. This share price information is delayed by 15 minutes.

How has the Olainfarm AS share price performed this year?

Shares in Olainfarm AS are currently trading at €7.1 and the price has moved by 8.23% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Olainfarm AS price has moved by 8.65% over the past year.

What are the analyst and broker recommendations for Olainfarm AS?

Of the analysts with advisory recommendations for Olainfarm AS, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Olainfarm AS is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Olainfarm AS next release its financial results?

Olainfarm AS is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Olainfarm AS dividend yield?

Olainfarm AS does not currently pay a dividend.

Does Olainfarm AS pay a dividend?

Olainfarm AS does not currently pay a dividend.

When does Olainfarm AS next pay dividends?

Olainfarm AS does not currently pay a dividend.

How do I buy Olainfarm AS shares?

To buy shares in Olainfarm AS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Olainfarm AS?

Shares in Olainfarm AS are currently trading at €7.1, giving the company a market capitalisation of £90.4m.

Where are Olainfarm AS shares listed? Where are Olainfarm AS shares listed?

Here are the trading details for Olainfarm AS:

Country of listing: Latvia
Exchange: RIX
Ticker Symbol: OLF1R
What kind of share is Olainfarm AS?

Based on an overall assessment of its quality, value and momentum, Olainfarm AS is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Olainfarm AS share price forecast 2020?

Shares in Olainfarm AS are currently priced at €7.1. At that level they are trading at 1.41% premium to the analyst consensus target price of 0.00.

Analysts covering Olainfarm AS currently have a consensus Earnings Per Share (EPS) forecast of 0.81 for the next financial year.

How can I tell whether the Olainfarm AS share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Olainfarm AS. Over the past six months, the relative strength of its shares against the market has been 18.18%. At the current price of €7.1, shares in Olainfarm AS are trading at 1.86% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Olainfarm AS PE Ratio?

The Olainfarm AS PE ratio based on its reported earnings over the past 12 months is 5.74. The shares are currently trading at €7.1.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Olainfarm AS?

Olainfarm AS's management team is headed by:

Veranika Dubitskaya - DMK
Martins Tambaks - CFO
Genadijs Melnis - CAD
Jelena Cudinovskiha - OTH
Jevgenijs Goncars - DSL
Lauris Macijevskis - CMG
Linda Litina - VBD
Vjaceslavs Krauklis - VRD
Karlis Krastins - SUB
Janis Buks - VSU
Gundars Berzins - CSU
Haralds Velmers - SUB
Andrejs Saveljevs - SUB
Ludmila Baskirova - GCN
Jana Gridasova - FID
Jeroen Weites - CMG
Elena Bushberg - CEO
Who are the major shareholders of Olainfarm AS?

Here are the top five shareholders of Olainfarm AS based on the size of their shareholding:

SIA Olmafarm Corporation
Percentage owned: 42.56% (5.99m shares)
Clearstream Banking SA Corporation
Percentage owned: 9.29% (1.31m shares)
Olfim OU Corporation
Percentage owned: 7.79% (1.10m shares)
Maligina (Anna Emilija) Individual Investor
Percentage owned: 7.79% (1.10m shares)
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund
Percentage owned: 1.28% (180k shares)
Similar to OLF1R
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.